MT1-MMP – A potential drug target for the management of the obesity

Pallavi Asthana; Xuanming Guo; Hoi Leong Xavier Wong

doi:10.1080/14728222.2022.2147271

MT1-MMP – A potential drug target for the management of the obesity

Pallavi Asthana
, Xuanming Guo
, Hoi Leong Xavier Wong^*

^*Corresponding author for this work

Research output: Contribution to journal › Editorial

1 Citation (Scopus)

Original language	English
Pages (from-to)	761-765
Number of pages	5
Journal	Expert Opinion on Therapeutic Targets
Volume	26
Issue number	9
DOIs	https://doi.org/10.1080/14728222.2022.2147271
Publication status	Published - 2 Sept 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

User-Defined Keywords

GDF15/GFRAL signaling
insulin resistance
MMP14
obesity

Access to Document

10.1080/14728222.2022.2147271

Cite this

@article{a618eb8c8e1e44268e469f30a73636a1,

title = "MT1-MMP – A potential drug target for the management of the obesity",

keywords = "GDF15/GFRAL signaling, insulin resistance, MMP14, obesity",

author = "Pallavi Asthana and Xuanming Guo and Wong, \{Hoi Leong Xavier\}",

note = "Funding Information: The presented work was kindly supported by the General Research Fund (12101019 and 12102020) (Wong HLX), Health and Medical Research Fund (06170056 and 08793626) (Wong HLX), National Natural Science Fund (81802838) (Wong HLX) and Guangdong Natural Science Foundation (2021A1515011128 and 2019A1515011851) (Wong HLX). Publisher copyright: {\textcopyright} 2022 Informa UK Limited, trading as Taylor \& Francis Group",

year = "2022",

month = sep,

day = "2",

doi = "10.1080/14728222.2022.2147271",

language = "English",

volume = "26",

pages = "761--765",

journal = "Expert Opinion on Therapeutic Targets",

issn = "1472-8222",

publisher = "Taylor and Francis Ltd.",

number = "9",

}

TY - JOUR

T1 - MT1-MMP – A potential drug target for the management of the obesity

AU - Asthana, Pallavi

AU - Guo, Xuanming

AU - Wong, Hoi Leong Xavier

N1 - Funding Information: The presented work was kindly supported by the General Research Fund (12101019 and 12102020) (Wong HLX), Health and Medical Research Fund (06170056 and 08793626) (Wong HLX), National Natural Science Fund (81802838) (Wong HLX) and Guangdong Natural Science Foundation (2021A1515011128 and 2019A1515011851) (Wong HLX). Publisher copyright: © 2022 Informa UK Limited, trading as Taylor & Francis Group

PY - 2022/9/2

Y1 - 2022/9/2

KW - GDF15/GFRAL signaling

KW - insulin resistance

KW - MMP14

KW - obesity

UR - https://www.scopus.com/pages/publications/85142234068

U2 - 10.1080/14728222.2022.2147271

DO - 10.1080/14728222.2022.2147271

M3 - Editorial

SN - 1472-8222

VL - 26

SP - 761

EP - 765

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

IS - 9

ER -

MT1-MMP – A potential drug target for the management of the obesity

UN SDGs

User-Defined Keywords

Access to Document

Other files and links

Cite this